Dec 30, 2025 09:15AM
Dec 30, 2025 09:15AM
Aug 19, 2024 04:15PM
Aug 19, 2024 08:00AM
May 1, 2024 08:00AM
Apr 15, 2024 08:00AM
Apr 1, 2024 06:30AM Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
Mar 5, 2024 08:05AM
Mar 5, 2024 08:00AM
Mar 5, 2024 08:00AM
Jan 2, 2024 08:00AM
Dec 14, 2023 08:00AM
Dec 1, 2023 08:04AM
Dec 1, 2023 08:00AM Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
Nov 16, 2023 08:00AM
Nov 6, 2023 08:00AM
Sep 29, 2023 08:00AM
Sep 27, 2023 08:00AM
Sep 21, 2023 08:03AM
Sep 21, 2023 08:00AM
Sep 21, 2023 08:00AM Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing, Company Also Receives $2.5 Million U.K. R&D Tax Credit
Sep 19, 2023 08:00AM
Sep 5, 2023 08:00AM
Aug 18, 2023 08:00AM
Aug 15, 2023 08:02AM
Aug 15, 2023 08:00AM
Aug 2, 2023 08:00AM
Jul 27, 2023 08:03AM Akari Therapeutcis (AKTX) Granted Nomacopan Orphan Drug Designation in EU for Treatment in Hematopoietic Stem Cell Transplantation
Jul 27, 2023 08:00AM
Jul 19, 2023 08:04AM
Jul 19, 2023 08:00AM
Jul 13, 2023 08:05AM
Jul 13, 2023 08:00AM
Jul 11, 2023 08:00AM
Jul 6, 2023 08:07AM Akari Therapeutcis (AKTX) Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Nomacopan for Treatment in Hematopoietic Stem Cell Transplantation
Jul 6, 2023 08:00AM
Jul 5, 2023 08:00AM
May 16, 2023 04:05PM
May 16, 2023 08:00AM
May 1, 2023 08:00AM
May 1, 2023 08:00AM
Apr 25, 2023 04:18PM Akari Therapeutcis (AKTX) Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
Apr 25, 2023 04:15PM
Apr 25, 2023 04:15PM
Apr 14, 2023 08:00AM
Apr 14, 2023 08:00AM
Apr 11, 2023 08:00AM
Apr 11, 2023 08:00AM
Apr 3, 2023 08:00AM Akari Therapeutics Announces a Case Study from the Phase 3 Part A Clinical Trial of Nomacopan in Pediatric HSCT-TMA Will Be Presented at The European Society for Blood and Marrow Transplantation (EBMT
Apr 3, 2023 08:00AM

322,200 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All